Kotra Industries Bhd (-ve)
SHARES in Kotra Industries Bhd (fundamental: 0.8/3, valuation: 1.1/3) closed nine sen or 6.47% lower at RM1.30 yesterday, on a volume of 363,900 shares, far exceeding the counter’s 200-day average volume of 18,520 shares.
It is the first time this year that the stock has triggered our momentum algorithm.
Kotra is involved in pharmaceuticals and consumer products. Its pharmaceutical brands include Axcel and Vaxcel, while its main brand under its consumer segment is its Appeton range of products.
For the first half of its financial year ending June 30, 2017 (1HFY17), Kotra reported a 39% increase in net profit to RM5.88 million, from RM4.22 million a year ago due to higher sales from export markets and a higher foreign exchange gain.
Revenue for 1HFY17 came in 2.4% higher at RM78.97 million from RM77.12 million a year ago. At the current share price, Kotra is trading at 1.25 times its book value.